Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.21.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets

    As of December 31,  
    2020     2019  
             
Net operating loss carryforward BiomX Inc.    

719

      -  
Net operating loss carryforward BiomX Ltd.     14,473       5,953  
Total deferred tax assets     15,192       5,953  
Valuation allowance     (15,192 )     (5,953 )
Net deferred tax assets     -       -  
Schedule of reconciliation of the federal statutory and effective tax rate

    As of December 31,  
    2020     2019  
             
Statutory U.S. federal income tax rate     (21 )%     (21 )%
U.S. vs foreign tax rate differential     (2 )     (2 )
Business Combination expenses     -       3.1  
Change in deferred tax asset valuation allowance     23       19.9  
Effective tax rate     - %     - %

Schedule of loss from operations before taxes on income
    As of December 31,  
    2020     2019  
             
United States     3,273       1,589  
Israel     26,813       18,974  
      30,086       20,563